These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 30342531

  • 1. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure.
    Martinelli AEM, Maranhão RC, Carvalho PO, Freitas FR, Silva BMO, Curiati MNC, Kalil Filho R, Pereira-Barretto AC.
    Lipids Health Dis; 2018 Oct 20; 17(1):242. PubMed ID: 30342531
    [Abstract] [Full Text] [Related]

  • 2. Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).
    Pahl MV, Ni Z, Sepassi L, Moradi H, Vaziri ND.
    Nephrol Dial Transplant; 2009 Aug 20; 24(8):2541-6. PubMed ID: 19297356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer.
    Mihajlovic M, Gojkovic T, Vladimirov S, Miljkovic M, Stefanovic A, Vekic J, Zeljkovic D, Trifunovic B, Kotur-Stevuljevic J, Spasojevic-Kalimanovska V, Zeljkovic A.
    Clin Biochem; 2019 Jan 20; 63():32-38. PubMed ID: 30500525
    [Abstract] [Full Text] [Related]

  • 6. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M, Pinzón-Cortés JA, Silva-Bermúdez LS, Ruiz-Manco D, Pérez-Matos MC, Jiménez-Mora MA, Mendivil CO.
    Lipids Health Dis; 2020 May 25; 19(1):106. PubMed ID: 32450892
    [Abstract] [Full Text] [Related]

  • 7. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men.
    Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A.
    Arterioscler Thromb; 1994 Oct 25; 14(10):1581-5. PubMed ID: 7918308
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
    Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P.
    Arterioscler Thromb; 1993 Jun 25; 13(6):815-25. PubMed ID: 8499401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
    Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR.
    J Clin Invest; 1989 Jun 25; 83(6):2018-24. PubMed ID: 2723070
    [Abstract] [Full Text] [Related]

  • 15. Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose.
    Chang CK, Tso TK, Snook JT, Huang YS, Lozano RA, Zipf WB.
    Acta Diabetol; 2001 Jun 25; 38(1):37-42. PubMed ID: 11487175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Contribution of cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase to HDL size distribution.
    Huesca-Gómez C, Carreón-Torres E, Nepomuceno-Mejía T, Sánchez-Solorio M, Galicia-Hidalgo M, Mejía AM, Montaño LF, Franco M, Posadas-Romero C, Pérez-Méndez O.
    Endocr Res; 2004 Aug 25; 30(3):403-15. PubMed ID: 15554357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients.
    Aslan I, Kucuksayan E, Aslan M.
    Lipids Health Dis; 2013 Apr 24; 12():54. PubMed ID: 23617853
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.
    Ozturk OH, Can Y, Yonden Z, Motor S, Oktay G, Kaya H, Aslan M.
    Lipids; 2013 Dec 24; 48(12):1217-26. PubMed ID: 24113910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.